Alterola Biotech, Inc. (ABTI)
OTCMKTS · Delayed Price · Currency is USD
0.0051
0.00 (0.00%)
Jan 16, 2026, 4:00 PM EST
Alterola Biotech Market Cap
Alterola Biotech has a market cap or net worth of $7.55 million as of January 20, 2026. Its market cap has decreased by -85.82% in one year.
Market Cap
7.55M
Enterprise Value
9.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since June 21, 2021, Alterola Biotech's market cap has decreased from 1.46B to 7.55M, a decrease of -99.48%. That is a compound annual growth rate of -68.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 7.55M | 72.54% |
| Dec 24, 2024 | 4.38M | -10.93% |
| Dec 19, 2023 | 4.92M | -87.82% |
| Dec 30, 2022 | 40.35M | -63.75% |
| Dec 31, 2021 | 111.33M | -92.35% |
| Jun 21, 2021 | 1.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |